BiPar Sciences presents interim phase 2 res... [Cancer Biol Ther. 2009] - PubMed

loading

Review [Breakthrough breast cancer treatment--PARP inhibitor, BRCA, and triple negative breast cancer]. [Gan To Kagaku Ryoho. 2010]
Review [Breakthrough breast cancer treatment--PARP inhibitor, BRCA, and triple negative breast cancer].
Hashimoto K, Tamura K. Gan To Kagaku Ryoho. 2010 Jul; 37(7):1187-91.
PARP inhibition in breast cancer. [Clin Adv Hematol Oncol. 2009]
PARP inhibition in breast cancer.
Garber J. Clin Adv Hematol Oncol. 2009 Sep; 7(9):573-5.
PARP inhibitors and their evolving role in breast cancer. [Oncology (Williston Park). 2011]
PARP inhibitors and their evolving role in breast cancer.
Roop RP, Ma CX, Ellis MJ. Oncology (Williston Park). 2011 Oct; 25(11):1033-4.
The potential of PARP inhibitors in genetic breast and ovarian cancers. [Ann N Y Acad Sci. 2008]
The potential of PARP inhibitors in genetic breast and ovarian cancers.
Drew Y, Calvert H. Ann N Y Acad Sci. 2008 Sep; 1138:136-45.
Review PARP inhibitor treatment in ovarian and breast cancer. [Curr Probl Cancer. 2011]
Review PARP inhibitor treatment in ovarian and breast cancer.
Weil MK, Chen AP. Curr Probl Cancer. 2011 Jan-Feb; 35(1):7-50.

BiPar Sciences presents interim phase 2 results for PARP inhibitor BSI-201 at Sa...
BiPar Sciences presents interim phase 2 results for PARP inhibitor BSI-201 at San Antonio Breast Cancer Symposium.
Cancer Biol Ther. 2009 Jan ;8(1):2-3.

PubMed
Treatment and follow-up of oral dysplasia - a systematic review and meta-analysi...
Treatment and follow-up of oral dysplasia - a systematic review and meta-analysis.
Head Neck. 2009 Dec ;31(12):1600-9.

PubMed
Differentiation rather than aging of muscle stem cells abolishes their telomeras...
Differentiation rather than aging of muscle stem cells abolishes their telomerase activity.
Biotechnol Prog. 2009 Jul-Aug ;25(4):1130-7.

PubMed
Checklist for optimization and validation of real-time PCR assays.
Checklist for optimization and validation of real-time PCR assays.
J Clin Lab Anal. 2009 ;23(3):145-51.

PubMed
Genetic and plasma variation of insulin-like growth factor binding proteins in r...
Genetic and plasma variation of insulin-like growth factor binding proteins in relation to prostate cancer incidence and survival.
Prostate. 2009 Sep 1 ;69(12):1281-91.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed